Category Archives: Scott Gottlieb

FDA awards $2.6M in grants for 3D bioprinting and biomedical research

The U.S Food and Drug Administration (FDA) has awarded grants to five research institutes for the study and improvement of biomanufacturing, including 3D bioprinting. Scott Gottlieb, MD, FDA Commissioner, said, “Advanced manufacturing technologies, such as continuous manufacturing, hold great promise for improvements in the reliability, flexibility, and cost-effectiveness of manufacturing for biological products.” “we awarded […]

Centinel Spine 3D printed implant achieves FDA approval

Additive manufacturing continues to aid in the production of medical-grade implants. From 3D printed cages built to support the spine to the development of biocompatible facial implants, 3D printed implants have displayed its functionalities over traditional medical procedures. Taking a step further to improve spinal treatments, Centinel Spine, a Pennsylvania-based spinal device development company, has […]

Leading 3D printing enterprises respond to FDA guidance for medical sector

3D printing for healthcare and medical applications is an area where significant progress has already been made. The recent statement by FDA Commissioner Dr. Scott Gottlieb on 3D printing for the medical sector also reaffirmed the agency’s commitment to a “new era of 3D printing of medical products.” 3D Printing Industry asked some of the […]

FDA makes statement concerning the future of 3D printing in medicine

The increasing availability of 3D printed medical devices, like hip implants or cranial plates, and the potential benefits of 3D printed drugs, makes additive manufacturing in healthcare hard to ignore. Committed to assuring the safety of such products, the FDA has been keeping a watchful eye on the technology’s progress, both internally and through the […]